Atlas Trials

Safety and Efficacy of Asacol 4.8 g/Day Versus Asacol 2.4 g/Day (ASCEND I)

Clinical trial NCT00577473 · COMPLETED

Trial details

NCT number
NCT00577473
Sponsor
Warner Chilcott
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Ulcerative Colitis
Start date
2001-02-01
Primary completion
2003-02-01
Enrollment
301

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.